Inactivation of FoxO proteins by phosphorylation is the result of a number of stimuli, including the insulin/IGF pathway. We were interested in the consequence of blunting this pathway by employing transgenic mice with tetracycline-controllable conditional expression of a constitutively active allele of FOXO3 under the control of the forebrain-specific CaMKII␣ promoter. Although transgene-expressing mice were viable, brain weight was reduced by 30% in adult animals. Brains showed an isocortex compression with normal cortical layering, and a size reduction in regions known to depend on adult neurogenesis, i.e., the olfactory bulbs and the dentate gyrus. On postnatal activation of the transgene, adult neurogenesis was also severely affected. Investigating the molecular basis of this phenotype, we observed enhanced apoptosis starting from embryonic day E10.5 and a subsequent loss of progenitors in the ventricular/subventricular zones, but not in the isocortex or the striatum of adult mice. The enhanced apoptosis was accompanied by increased expression of PIK3IP1, which we identified as a direct transcriptional target of FOXO3. Transfection of Pik3ip1 into differentiating neural progenitors resulted in a significant reduction of viable cells. We therefore conclude that neural progenitors are particularly vulnerable to FOXO3-induced apoptosis, which is mediated by PIK3IP1, a negative PI3 kinase regulator. Of the different forkhead transcription factor subclasses, the subclass O (FOXO) has attracted considerable interest due to the association of its loss-of-function homologues in Caenorhabditis elegans and Drosophila melanogaster with reduced life span. Furthermore, their activation by caloric restriction results in a prolongation of life span in these animal models (4 -7). In vertebrates, 4 different FoxOs (FoxO1, FoxO3, FoxO4, and FoxO6) with both overlapping and diverging expression patterns have been described (8 -10). At the transcriptional level, there is an overlap of expression in different regions of the murine brain, e.g., in the cortex and hippocampal formation for FoxO1, FoxO3, and FoxO6, suggesting a functional redundancy (11, 12) . Several kinases have been reported to exert activating and inactivating phosphorylation of FOXOs, the best known being AKT/PKB as an effector kinase of the insulin/IGF receptor pathway (3). AKT phosphorylates FoxO3 at residues Thr32, Ser253, and Ser315, leading to an enhanced exclusion of FOXOs from the nucleus. Target genes of FOXOs in numerous tissues include cell cycle inhibitors (p21, p27, p19 INK , p19 ARF ; refs. 13-16) and genes involved in apoptosis or autophagy induction (Bim, FasL, Bnip3; refs. 3, 17) . Moreover, FOXO target genes are involved in neuronally regulated food intake (Agrp, Npy, Pomc; refs. 18, 19) .
Insulin-like growth factor (IGF) signaling is essential for proper brain development (1) . Disruption of the IGF axis leads to reduced brain size and loss of hippocampal granule and striatal parvalbumin-containing neurons. Lack of a downstream effector of the IGF axis, AKT3, also leads to decreased brain size (2) . The forkhead box O (FOXO) transcription factors are prominent downstream effectors of this pathway that have been reported to be inactivated by AKT-mediated phosphorylation (3) .
Of the different forkhead transcription factor subclasses, the subclass O (FOXO) has attracted considerable interest due to the association of its loss-of-function homologues in Caenorhabditis elegans and Drosophila melanogaster with reduced life span. Furthermore, their activation by caloric restriction results in a prolongation of life span in these animal models (4 -7). In vertebrates, 4 different FoxOs (FoxO1, FoxO3, FoxO4, and FoxO6) with both overlapping and diverging expression patterns have been described (8 -10) . At the transcriptional level, there is an overlap of expression in different regions of the murine brain, e.g., in the cortex and hippocampal formation for FoxO1, FoxO3, and FoxO6, suggesting a functional redundancy (11, 12) . Several kinases have been reported to exert activating and inactivating phosphorylation of FOXOs, the best known being AKT/PKB as an effector kinase of the insulin/IGF receptor pathway (3) . AKT phosphorylates FoxO3 at residues Thr32, Ser253, and Ser315, leading to an enhanced exclusion of FOXOs from the nucleus. Target genes of FOXOs in numerous tissues include cell cycle inhibitors (p21, p27, p19 INK , p19 ARF ; refs. [13] [14] [15] [16] and genes involved in apoptosis or autophagy induction (Bim, FasL, Bnip3; refs. 3, 17) . Moreover, FOXO target genes are involved in neuronally regulated food intake (Agrp, Npy, Pomc; refs. 18, 19) .
The physiological role of FOXOs has been documented by animal models lacking either one or several of the FoxO-encoding genes (8, 9, 12, 20 -22) . Less is known about the consequences of enhanced activity of FoxOs, which may occur due to deficiencies in insulin receptor signaling or malnutrition, always reflecting low-energy levels. Work on flies revealed that overexpression of dFOXO results in a general growth reduction (23) but also showed a dFOXO-mediated life-span extension when activated in the pericerebral fat body (6) . Overexpression of FoxO1, FoxO4, and FoxO6, but not FoxO3, leads to severe gastrulation defects in Xenopus embryos (10) . For FoxO3, it was shown in cultured rat cerebellar granule cells that its constitutive activation by mutation of the Akt-sensitive residues into alanines leads to enhanced apoptosis via induction of FasL (3) .
We were interested to know whether constitutive activation of FOXO in the murine brain may lead to phenotypes resembling IGF or AKT3 deprivation. To identify the role of aberrant insulin/IGF signaling during brain development and plasticity, we expressed a constitutively active allele of FOXO3 under the control of the CaMKII␣ promoter during embryogenesis and adulthood.
MATERIALS AND METHODS

Animal experimentation
All animal experimentation procedures were approved by the Regierungspräsidium Tübingen (TVA 0.110 and 999), in accordance with the regulations of the German Federal Law on Care and Use of Laboratory Animals, and with the European Communities Council Directive of 24 November 1986 (86/609/EEC). All animals were kept on a 12-h lightdark cycle and had free access to water and food at any time.
We generated transgenic mice bearing a hemagglutinintagged triple mutant of FOXO3 in a bicistronic vector containing a luciferase reporter under the transcriptional control of a 7x tetracycline (tet) operator (see Fig. 1A and refs. 3, 24, 25) . These transgenic mice were crossed with mice expressing the artificial tet transactivator (tTA) under the control of the CaMKII␣ promoter in order to obtain forebrain-specific and neuronal expression in mice harboring both transgenes, the constitutively active FOXO3 (FOXO3-CA) allele and the CaMKII␣ tTA construct (Fig. 1A and ref. 26 ). In the absence of doxycycline, the tet transactivator will bind to the 7x tet operator and initiate transcription of both transgenes, luciferase and FOXO3-CA. If desired, doxycycline (Sigma-Aldrich, Taufkirchen, Germany) was administered in the drinking water at a concentration of 1 mg/ml supplemented with 10 mg/ml sucrose in dark bottles during embryogenesis and lactation. The doxycycline solution was changed Ն1ϫ/wk. Administration of doxycycline abolishes transgene transcription. All FOXO3-CA mouse experiments were performed on a mixed CD1/NMRI outbred background.
For in vivo imaging, the animals were injected intraperitoneally with 400 l of a 7 mg/ml luciferin solution. After 5-10 min, animals of either sex were imaged using a Xenogen IVIS 200 system (Caliper Life Sciences, Hopkinton, MA, USA).
For histological analyses, the animals were euthanized by CO 2 and decapitated, and the brains were prepared and immersion-fixed in Bouin's fixative for subsequent Nissl staining, or frozen unfixed using a heat block positioned over liquid nitrogen. Brains preserved by the latter method were stored at Ϫ80°C until cryosectioning.
Time pregnant females were designated embryonic day 0.5 (E0.5) after detection of a vaginal plug at 8 AM. At the desired points in time, pregnant dams were sacrificed, and the uteri were removed. Staging was then performed according to the Edinburgh mouse atlas project for embryo staging (http://www.emouseatlas.org/emap/ema/ theiler_stages/StageDefinition/stagecriteria.html).
Cell culture
For neurosphere cultures, regions adjacent to the lateral ventricles were trypsinized with a fire-polished pipette after the removal of skin, cartilage, and meninges at E11.5 and propagated in Neurobasal medium with 2% B27 supplement without vitamin A (all from Invitrogen, Karlsruhe, Germany) and 20 ng/ml EGF (Sigma). The day before transfection, singularized stem/progenitor cells were plated onto laminincoated culture dishes in Neurobasal medium with B27 with vitamin A and without EGF. Transfection was achieved using the Lipofectamine LTX reagent (Invitrogen). Apoptosis was assessed using AnnexinV-APC and 7-AAD on a FACS Canto employing the FACSDiva software (BD Biosciences, Heidelberg, Germany). Luciferase reporter assays were performed with HEK293 cells using calcium phosphate precipitation for transfection. Luciferase was assessed using the dual luciferase reporter assay using actin Renilla for normalization (Promega, Mannheim, Germany).
Behavioral testing
We separated the males and allowed them to take possession of their new housings for Ն1 wk with some enrichment by placing cardboard and paper towels into the cages before behavioral testing. During this time, the mice got habituated to handling. We recorded all data with an automated video tracking and analysis system (Biobserve, Bonn, Germany).
For the open-field test, we placed the mice into a dark 50-ϫ 50-cm arena surrounded by 50-cm sidewalls and observed for 30 min. We further assessed anxiety by the elevated plus maze. Therefore, we placed the animals on an open arm and let them explore the maze for 5 min. If the animal fell off the maze before the end of the 5-min observation time, its data were not included in the analysis. We summed up both open arms and both closed arms for analyses. The accelerating RotaRod apparatus (Med Associates, St. Albans, VT, USA) served to measure motor learning and coordination. For each test, we placed the mice in the RotaRod cylinder, starting first at 4 rpm for 1 min and then accelerating up to 40 rpm for a maximum observation time of 5 min. We tested the animals for 4 consecutive days, with 3 trials/d separated by Ն15-min intertrial intervals. The device recorded the latency to fall by using the RotaRod 1.2.0 software (Med Associates). The Morris water maze consists of a round pool with a diameter of 120 cm, half filled with water. A platform 10 cm in diameter with a rough surface is hidden at no more than 0.5 cm below the water. We placed visual cues outside the pool and performed training for 5 consecutive days with 4 swims of 1 min/animal. The animals learned to find the platform from 4 different positions that were used 1ϫ/d. The performed probe trials were like normal training runs with all animals starting from the same position.
Immunohistochemistry
For Nissl staining, the brains were embedded into paraffin and sectioned using a Microm HM355S microtome (Thermo Scientific, Waldorf, Germany). Cryosections were made using a Leica CM1900 cryomicrotome (Leica Microsystems, Wetzlar, Germany). Sections were fixed with either 4% PBSbuffered formaldehyde (4°C) or methanol (Ϫ20°C) and then permeabilized with 0.1% Triton X-100 (Sigma) in 0.1% citrate and blocked. The following primary antibodies were employed: goat ␣NGN2, goat ␣CDP, and goat ␣FOXP2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); rabbit ␣TBR2 and rabbit ␣CTIP2 (Abcam, Cambridge, UK); rabbit ␣Ki-67 (Thermo Scientific), rabbit ␣-cleaved caspase 3 (Cell Signaling via New England Biolabs, Frankfurt, Germany); and rabbit ␣FOXO3 (Millipore, Billerica, MA, USA). The BCL11b antibody was kindly provided by Stefan Britsch (Ulm University). Secondary antibodies were labeled with Alexa Fluor 488 and Alexa Fluor 594 dyes (Invitrogen). Counterstaining was performed with DAPI, and sections were mounted in Mowiol 4 -88 (Sigma). TUNEL reactions were performed using the fluorescein-employing in situ cell death detection kit (Roche, Mannheim, Germany). At least 3 sections/animal were analyzed. Fluorescence microscopy was performed using an AxiovertMot 200 (Zeiss, Oberkochen, Germany).
Immunoblotting
Dissected tissues were snap-frozen in liquid nitrogen and lysed with steel beads or with an insulin syringe with a 26-gauge needle. The following buffer was used for all extracts: 20 mM HEPES (pH 7.9), 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 1 mM DTT, 1 mM PMSF, 1 mM sodium orthovanadate, protease inhibitors (Roche), and phosphatase inhibitors (Roche). This buffer was described as buffer C by Dignam et al. (27) . The extract was cleared by centrifugation in a refrigerated centrifuge. Luciferase reporter activity was measured using 5 l of the generated extracts for immediate assessment of transgene expression (LB9507; Berthold Detection Systems, Pforzheim, Germany). Antibodies employed were rabbit ␣FKRL1 (Santa Cruz Biotechnology), rabbit ␣TBR2 (Abcam), and rabbit ␣-actin (Sigma).
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts from transfected HEK293 cells were generated as published previously (27) , and subjected to the EMSA protocol published previously (28) .
RNA analyses
RNA was prepared from snap-frozen tissue using the RNeasy lipid tissue mini kit and the Tissue Lyser II (both from Qiagen, Hilden, Germany). Concentrations were measured using a Nanodrop 2000 device (Thermo Scientific). Complementary DNA synthesis was performed using the VILO kit (Invitrogen). Quantitative reverse transcriptase PCR (qPCR) was performed using a Light Cycler 480 and employed so-called universal probes (Roche). The assays were designed using a modified Primer3 program optimized to screen for intron-overlapping primers.
Microarray analysis
Microarray analyses were performed using 200 ng total RNA from E12.5 forebrains as starting material and 5.5 g ssDNA per hybridization (GeneChip Fluidics Station 450; Affymetrix, Santa Clara, CA, USA). Total RNA was amplified and labeled following the Whole Transcript Sense Target Labeling Assay (http://www.affymetrix.com). Labeled ssDNA was hybridized to Mouse Gene 1.0 ST Affymetrix GeneChip arrays (Affymetrix). The chips were scanned with an Affymetrix GeneChip Scanner 3000, and subsequent images were analyzed using Affymetrix Expression Console software (Affymetrix). A transcriptome analysis was performed using BRB-ArrayTools developed by Dr. Richard Simon and the BRB-ArrayTools Development Team (http://linus.nci.nih.gov/BRBArrayTools.html). Raw feature data were normalized, and log 2 intensity expression summary values for each probe set were calculated using robust multiarray average (RMA; ref. 29) .
Filtering
Genes showing minimal variation across the set of arrays were excluded from the analysis. Genes whose expression differed by Ն1.5-fold from the median in Ն20% of the arrays were retained.
Class comparison
We identified genes that were differentially expressed among the two classes using a 2-sample t test. Genes were considered statistically significant with a value of P Ͻ 0.05 and a fold change between the 2 groups of Ն1.5-fold. Complete microarray data are available at Gene Expression Omnibus (GEO accession number: GSE21089).
siRNA experiments
The clones of the L428 classical Hodgkin lymphoma cell line stably expressing FOXO3(A3)ER were created by transfection with the pcDNA-FOXO3(A3)ER vector using a nucleofector device (Lonza, Cologne, Germany) followed by selection with 1 mg/ml of G-418 sulfate (Calbiochem, Darmstadt, Germany). Addition the latter, a 1-sided paired t test was applied since the questions were 1-sided (Is there less specific cell death?), and the values were grouped per experiment. Error bars represent sd. No Bonferroni adjustment was made for multiple testing. The following cutoff levels were used to indicate the rejection of the null hypothesis: P Ͻ 0.05, P Ͻ 0.01, and P Ͻ 0.001.
RESULTS
Genetic manipulation of FOXO3 in the murine brain
We generated mice carrying the mutant allele FOXO3-CA, with 3 alanine substitutions in the AKT/PKB phosphorylation sites (24) . These transgenic mice were crossed with mice expressing the tet transactivator under the control of the CaMKII␣ promoter (26) in order to obtain forebrain-specific expression in mice harboring both transgenes. Double-transgenic (dtg) mice bearing both the FOXO3-CA allele and the CaMKII␣ tTA construct and their littermate controls were subsequently analyzed (Fig. 1A) . Of the generated FOXO3 founders, we maintained the two lines with highest protein expression levels for further analyses (Fig. 1C, E) . Dtg mice were viable, and allele distribution followed mendelian inheritance ratios. Using in vivo imaging, we demonstrated forebrain-specific expression (Fig. 1B) , additionally confirmed by luciferase measurements and Western blot analysis (Fig. 1D, F) . A high expression of exogenous FOXO3 was detectable in the olfactory bulbs, the cortex, the hippocampus, and the striatum, but there was no expression of the exogenous FOXO3 detectable in the cerebellum, or any other organ tested (Fig. 1G ).
Constitutive activation of FOXO3 in the developing murine brain leads to a reduction in brain size
In both transgenic lines, the brain size of adult dtg mice bearing a FOXO3-CA allele under the control of the CaMKII␣ promoter was reduced by ϳ30% as compared to wild-type (wt) or single-transgenic (stg) mice ( Fig. 2A, B,  E, F) . At the histological level, we observed a size reduction of the olfactory bulbs, the cortex, the striatum, thalamic nuclei, and an almost absent dorsal dentate gyrus (DG), i.e., a generally smaller forebrain (Fig. 2C, D) . The cerebellum, a site of high endogenous FOXO3 expression but not targeted by the CaMKII␣ promoter, appeared normal ( Fig. 2A, B, D) , and so were levels of endogenous FOXO3 (Fig. 1F) . Size reductions were most obvious in those parts of the brain with the highest FOXO3-CA expression (Figs. 1D, F and 2A-D) .
Since the total cortical thickness was remarkably reduced in the dtg animals, we sought to elucidate whether a distinct cortical layer was missing or reduced, as an indication for a particular susceptibility to the genetic manipulation. The murine neocortex consists of 6 layers. Layer formation, except for layer I, proceeds in an insideout pattern starting from E10.5 in mice (31) (32) (33) . Therefore, we measured the primary motor cortex thickness (bregma 0.5-0.38 mm according to ref. 34) and stained for the different cortical layers: CDP for layer II-IV, Ctip2/Bcl11b for layer V, and FoxP2 for layer VI (Fig. 2F) . We observed a reduction of all layers, but this was proportional to the reduction in total cortical thickness, i.e., all layers were affected to a similar extent on expression of the transgene (Fig. 2H ). In addition, we assessed the area covered by the striatum (Fig. 2I) . At the age of 3 mo, the area covered by the striatum was significantly smaller in dtg vs. control animals. Genetic manipulation of FOXO3 in the mouse brain. A) Schematics of the introduced mutations, the vector construct, which was used for the creation of the transgenic mice, the promoter construct used, and a breeding strategy. B) In vivo imaging of dtg and control (ctrl) mice shows brain-specific expression of the reporter transgene. C) Luciferase measurements from forebrain protein extracts from two different transgenic lines (examples). D) Luciferase measurements from protein extracts from different brain regions (examples). E) Immunoblot of the extracts in C probed with an antibody for FOXO3 and actin as a loading control. F) Immunoblot of the extracts in D probed with an antibody for FOXO3 and actin as a loading control. G) Immunoblot of extracts of different tissues probed with an antibody for FOXO3 and actin as a loading control. Exogenous FOXO3 is HA tagged, and therefore migrates slightly more slowly (top arrowheads) than the endogenous one (bottom arrowheads). 7xtetO, 7x tet operator; cerebell., cerebellum; DBD, DNA binding domain; NES, nuclear export sequence; NLS, nuclear localization sequence; rlu, relative light unit; telenc., telencephalon. Behavioral alterations in CaMKII-tTA/FoxO3-CA mice Given the massive reduction in brain size, we examined potential motor or behavioral abnormalities in transgenic mice.
We performed a series of behavioral tests, including the open field test for a general assessment of the exploratory and motor activity of our mice. When placed into an open field, dtg mice were significantly more active than their control littermates (Fig. 3A) . They covered a longer distance in all parts of the open field, i.e., the outer, the intermediate, and the central zones leading us to test the hypothesis that they might be less anxious. Indeed, when tested in the elevated plus maze, a paradigm of anxiety-related behavior, the dtg mice spent more time on the open arms of the maze than , and Morris water maze probe trials after 1 wk and 4 mo (E), respectively. n dtg ϭ 11, n ctrl ϭ 8 for A, C, D; n dtg ϭ 10, n ctrl ϭ 6 for B. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001. their control littermates, indicating a reduced level of anxiety (Fig. 3B) . The RotaRod was used for the analysis of motor learning and performance. As for motor learning, the dtg mice acquired the task a little bit slower than the control mice, but starting from d 2, all mice performed equally well on the RotaRod (Fig. 3C) .
Since the hippocampus is critically involved in learning and memory consolidation, the severe reduction in size of the dorsal DG led us to investigate the spatial learning and memory performance using the Morris water maze (Fig. 3D) . Interestingly, the dtg mice showed a similar learning behavior as the control mice. However, they performed less well in a probe trial 1 wk after the end of the training period (Fig. 3E) . When the probe trial was performed 4 mo later, the dtg animals performed significantly worse compared to control littermates, indicating a lack in memory maintenance (Fig. 3E) . Taken together, the dtg mice exhibited hyperactivity, reduced anxiety, normal spatial learning, and defects in spatial memory maintenance.
Temporal and spatial characterization of FOXO3-CA expression during embryogenesis
The reduced brain size in adult mice could be a consequence of neuronal loss during brain development, either embryonically or postnatally. Therefore, we aimed to determine at what stage of differentiation the loss of brain mass occurred. To this end, we analyzed dtg embryos at various points in time by histology. We first characterized the onset of transgene expression using both the luciferase reporter and Western immunoblotting for FOXO3 (Fig. 4A, B) . Luciferase expression was detectable as early as E9. 5 . This means that FOXO3-CA is expressed before the onset of neuronogenesis at E10.5 (31-33), i.e., before the apparent cell cycle exit and the terminal differentiation of neural progenitors. Endogenous FOXO3 is also readily detectable starting from E10.5, as is transgenic FOXO3 (Fig. 4B) . To validate this finding, we bred the LacZ/ alkaline phosphatase (Z/AP) reporter mice together with the CaMKII␣-tTA and the tetO-Cre mice, as described previously (35) . The developing forebrains of E12.5 embryos were stained for recombined loci as indicators for preceding CaMKII␣ promoter activity (Fig. 4C) . It is evident here that the lateral ganglionic eminence, the precursor of the striatum and a part of the developing cortex, is affected by the promoter activity. Using immunofluorescence staining, we observed a prominent expression of FOXO3-CA adjacent to the lateral ventricles in the ventricular zone, which develops into the subventricular zone later (Fig. 4D) . These are regions where proliferating progenitors reside during development and throughout adulthood.
Alterations of gross morphology in dtg animals were readily detectable at E16.5 (examples in Fig. 4E ; full data set in Supplemental Data), suggesting that there was a reduction of cellular mass well before this time point. We observed a very pronounced phenotype in the transgenic line, with higher transgene expression during embryonic development, leading to a reduced cortex and strongly affected ganglionic eminences (precursors of the striatum; Fig. 4E, right panel) . These changes were also apparent in the second transgenic line, albeit less pronounced (Fig. 4E, left panel) .
Apoptosis is increased during development in murine brains expressing FOXO3-CA
Given the early onset of the transgene expression at E9.5 and the associated loss of cell mass already at E16.5, we analyzed the rate of apoptosis at E10.5 and E12.5 using the TUNEL assay (Fig. 5B) . We observed ϳ2-fold higher numbers of TUNEL-positive signals in dtg as compared to control animals already at E10.5. The number of apoptotic cells increased strongly in dtg animals at E12.5, whereas it remained constant in the control animals, showing that the continuous expression of the FoxO3-CA allele yielded increasing amounts of apoptotic cells. TUNEL results were confirmed by staining for cleaved caspase 3 in E12.5 sections (Fig.  5D) . Apoptosis was strongest in the regions adjacent to the lateral ventricles from the frontal cortex to the amygdaloid neuroepithelium and colocalized with the sites of FOXO3-CA expression (Fig. 5A, C, D) . Outer cortical regions, which harbor the most differentiated neuronal subpopulations in the murine forebrain at this time point, did not contain as many TUNEL signals as the proliferative compartment. At E12.5, the dorsal part of the thalamic neuroepithelium also contained some TUNEL-positive nuclei in dtg animals, whereas they were not to be found in control animals (Fig. 5A) .
The transgene was expressed in the cortex, the hippocampus, and the striatum of adult animals (Fig.  5E ). We also analyzed apoptosis in brains from adult animals by the TUNEL reaction, and there we observed enhanced apoptosis in the DG of 3-mo-old animals but not in the corresponding striatum, nor in the cortex (Fig. 5F ). We did not observe statistically significant differences of apoptosis in 6-mo-old animals (Fig. 5F ).
Progenitors are reduced adjacent to the lateral ventricles in FOXO3-CA mice
The constitutively active form of FOXO3 used in this study was reported to induce apoptosis in cultured rat cerebellar granule cells by inducing the expression of FasL (3). Therefore, we analyzed the mRNA expression levels of FasL and several other apoptosis-inducing factors, as well as known FOXO3 target genes, such as p21, p27, and ARF, from E9.5 to E12.5 (Fig. 6B, C) . Although we observed statistically significant changes in the expression of p27, Bim, and TRAIL at E11.5, these changes were rather moderate and therefore of unclear relevance for the observed biological effects. Other targets, such as FasL, showed considerable variation and, hence, differences in gene expression were not statistically significant (Fig. 6C) . To further elucidate possible mechanisms responsible for the increase in apoptosis, we performed expression profiling of mRNA isolated from E12.5 forebrains of dtg vs. stg embryos using microarray analysis (Fig. 6A) . As anticipated from the qPCR data, none of the FOXO3 target genes described in the literature was regulated at a statistically significant level in the in vivo situation. The degree of total expression level changes was small, i.e., 80 genes were differentially regulated, and the highest expression level changes were a 4.7-fold up-regulation of Olig3 and a 2.5-fold down-regulation for Ncapg2 using a cutoff of 1.5-fold changes and P Ͻ 0.05 (Fig. 6A) . The mRNA levels of 55 genes were up-regulated, whereas downregulation was observed for 25 genes. For selected genes, we confirmed the differences in expression by qPCR. There, we observed a statistically significant up-regulation of Wnt3, Unc5c, Ptch1, and Pou3f2 in the dtg animals (Fig. 6D) . On the other hand, we observed a small but statistically significant down-regulation of FoxG1, Fzd8, Wnt7a, and Ncapg2 (Fig. 6E) . A marker of cortical progenitors, Eomes/Tbr2, was identified to be down-regulated in a subset of dtg as compared to stg animals. We validated this result by Western immunoblotting and by staining E12.5 sections for TBR2 (Fig.  6F, G, I ). TBR2-positive cells seem to accumulate outside the ventricular zone in both the control and the dtg animals. However, there are significantly less TBR2-positive cells within the proliferative compartment, i.e., the DAPI-rich ventricular zone (Fig. 6G) . We confirmed this result by staining for NGN2 (Fig. 6H ). Quantification shows a reduction of progenitors in the vicinity of lateral ventricles at E12.5 (Fig. 6I ).
Pik3ip1 is a direct target gene of FOXO3, and its expression in neural progenitors leads to increased cell death
Two publications described the consequences of FoxO3 or combined FoxO deficiency in neural stem cells (12, 22) . Both groups observed an increase in brain size as the main feature of absent in vivo FOXO activity and identified new target genes of FOXOs by analyzing gene expression profiles of cultured neurospheres. One of the genes being down-regulated in both data sets and being up-regulated in our data set is Pik3ip1, a negative regulator of class Ia phosphatidylinositol-3-kinase (Pi3k; refs. 36, 37). We confirmed the observed changes in mRNA expression by qPCR (Fig. 7A) .
We asked whether Pik3ip1 is a direct target gene of FOXO3. Therefore, we analyzed the 5=-region of the murine Pik3ip1 gene for FOXO consensus sites. We identified a perfect match at position Ϫ912 and an imperfect one at Ϫ116.
We then cloned fragments comprising these putative sites, as well as a minimal fragment without detectable FOXO binding sites, into luciferase reporter constructs and assayed the promoter activity in cotransfection assays (Fig. 7B) . Indeed, FOXO3 enhances the activity of the core promoter. In EMSAs, we could confirm that FOXO3 could indeed bind to these putative binding sites (Fig. 7C) .
Next, we cloned the cDNA of Pik3ip1 into a bicistronic vector with a GFP reporter and transfected differentiating embryonic neural progenitors in order to find out whether neural progenitors are vulnerable to PIK3IP1-induced cell death. One day after transfection, cells were analyzed by flow cytometry for signs of apoptosis or cell death (Fig. 7D) . We detected a significant increase in the amount of apoptotic and dead cells in the samples that had been transfected with Pik3ip1 as compared to those transfected with the empty expression vector in the GFP-positive fraction (Fig. 7D) . Therefore, we conclude that increased levels of PIK3IP1 could be responsible for the observed depletion of neural progenitors in our dtg animals. Given that PIK3IP1 was shown to augment apoptosis in hepatocytes (37) we asked whether it also contributes to FOXO3-induced apoptosis in human cells. Previously, we could show that FOXO1 induces apoptosis in classical Hodgkin lymphoma cell lines (38) . Therefore, we stably expressed the inducible constitutively active version of FOXO3, FOXO3(A3)ER in various lymphoma cell lines and induced its translocation by adding 4-OHT (Fig. 7E) . As for the dtg brains, we observed induction of Pik3ip1 expression in all cell lines Western blot for forebrains from E12.5 animals. G) Expression of TBR2 at the lateral ventricles at E12.5. ctrl, control; ctx, cortex; lv, lateral ventricle. H) Expression of NGN2 and FOXO3 adjacent to the lateral ventricles at E12.5. Scale bars ϭ 100 m. I) Quantification of G and H from 3 embryos/group; A, D, E) n ctrl ϭ 5, n dtg ϭ 5. B, C) Numbers of pairs per age: n E9.5 ϭ 4, n E10.5 ϭ 11, n E11.5 ϭ 10, n E12.5 ϭ 7. An unpaired 2-sided Student=s t test was performed in order to test for statistical significance under the assumption of a normal distribution; no Bonferroni adjustment was made for multiple testing (B-E, I). *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001. tested (Fig. 7E) . To investigate whether down-regulation of Pik3ip1 might counteract apoptogenic effects of FOXO3 activation, we transfected L428-FOXO3(3A)ER cells with siRNA specific for Pik3ip1 (36) or with control RNA (Fig. 7F) . At 48 h after treatment with 4-OHT, FOXO3-induced apoptosis was significantly repressed in cells treated with specific siRNA in comparison with cells treated with control RNA. Therefore, we conclude that induction of Pik3ip1 contributes to FOXO3-induced apoptosis.
Postnatal activation of the FoxO3-CA transgene affects brain structures dependent on adult neurogenesis
Given the losses of neural progenitors when the FOXO3-CA transgene is active during embryogenesis, we tested the hypothesis that this transgene will also affect postnatally derived neural progenitors. Therefore, we administered doxycycline during embryonic and early postnatal development in order to switch off the system (Fig. 8A) . We then activated transgene expression by removing doxycycline at 4 wk of age (changing to pure drinking water), and brains were analyzed 20 wk later. The brains of dtg animals from these breedings were smaller than the ones from their littermates when the animals were 6 mo of age (Fig. 8B,  D) . As anticipated, structures dependent on postnatal neurogenesis were affected in the dtg animals, i.e., the olfactory bulbs and the DG (Fig. 8B) . We then went on to quantify apoptosis in the different structures of the brains of mice that had received doxycycline during embryogenesis and until 10 wk of age and were kept without doxycycline for another 20 wk. We could not observe enhanced apoptosis in the cortex or the striatum of these mice (Fig. 8E) . However, we saw significantly enhanced apoptosis in the DG, a region in which postnatal neurogenesis occurs (Fig. 8E) .
These data show that constitutive activation of FOXO3 leads to reductions of brain size of both embryonic and postnatal neurogenic sites.
DISCUSSION
The CaMKII␣-tTA/FoxO3-CA mice show embryonic and postnatal effects of FoxO3 during brain development
We have generated transgenic mice expressing a constitutively active FOXO3 under the control of the CaMKII␣ promoter. These mice are viable and appear normal but have a smaller brain with a loss of neurons in the olfactory bulbs, the cortex, the striatum, thalamic regions, and most notably the DG. The olfactory bulbs and the DG, as sites known to depend on adult neurogenesis, were also affected by this genetic manipulation when the transgene was activated only postnatally. Although the brains of dtg mice were severely reduced in size, these mice did not show any behavioral alteration at the first glance. Their hyperactivity in the open field may be indicative of a reduction of cortical functions but might also be attributed to a partial loss of the amygdala, leading to reduced anxiety. Indeed, the CaMKII␣ promoter is active in the amygdala (26) . Interestingly, reduced anxiety had also been observed in mice lacking FoxO3 (39) . We think that the cortex and the amygdala reductions in our animals resulting from the depletion of cellular mass during embryogenesis could explain most of the anxiolytic phenotype of our mice. Also, the striatum is reduced in size, but so far, we did not detect any motor abnormality that may point to a general dysfunction of the basal ganglia. The performance of the dtg mice in the Morris water maze surprised most: they learned as efficiently as their control littermates. Given the severe reduction of the dorsal DG in these animals, we conclude that memory formation is not primarily dependent on this part of the hippocampal formation. In contrast, spatial memory maintenance is obviously dependent on the functional integrity of the dorsal DG.
The phenotype of our mice resembles that of the Akt3 knockout (2) . These mice also show a 30% reduction in brain size. It can be assumed that a knockout of Akt3 results in an enhanced activation of FOXOs in the brain. Our result of smaller forebrains of animals with a constitutive activation of FOXO3 indeed provides a molecular explanation for the Akt3-knockout phenotype. Both data sets underline the role of the Akt pathway and FoxO3 in neuronal development. The phenotype of our mice is complemented by the data on the general FoxO3-and combined FoxO-knockout mice: the knockout animals have larger brains (12, 22) , and stem cells from these animals are more rapidly exhausted with a lack of neuronal differentiation capacity. The deletion of further upstream regulators of FoxO3, such as the Igf1 knockout, also results in the formation of smaller brains (1) . All these data point to the necessity of an intact IGF1 axis during embryonic and postnatal brain development.
Our histological analyses showed a general atrophy of all isocortical layers in dtg mice with no preference for a particular layer in dtg animals. Given the fact that cortical layering occurs throughout embryonic development starting from E10.5 through E16.5, we conclude from our data that the introduced transgene affects all phases of cortex formation and thus acts in a vulnerable time window.
CaMKII␣-tTA/FoxO3-CA forebrains show a reduction of neural progenitors Constitutively active FOXO3 was shown previously to induce apoptosis in cultured rat cerebellar granule cells (3) and to be embryonically lethal in flies (6) . Therefore, we tested whether elevated apoptosis is relevant for the observed loss in cell mass. Indeed, this was the case for the embryos, whereas we did not detect obvious ongoing apoptosis in the adult animals outside neurogenic niches. In fact, the most affected regions in the embryonic brains were those reported to serve as the proliferative compartment, i.e., the ventricular zones.
In subsets of our microarray cohort, we also observed a down-regulation of Tbr2. The product of Tbr2 is expressed in mitotic neural progenitors, termed type 2a to type 3 intermediate progenitor cells by Hodge et al. (40) in the context of postnatal neurogenesis in the DG. When inspecting the ventricular zone adjacent to the lateral ventricles, we also observed a reduction of NGN2-positive cells, supporting the view that progenitors are being lost on their way from the ventricular zone to the destined cortical layer. In conjunction with the enhanced OLIG3 expression (41), a thalamic marker, and elevated OTX2 (42), a midbrain marker, as well as the altered WNT3 and WNT7a patterns (43), we reason that our microarray data reflect an overrepresentation of thalamic regions at the expense of cortical regions, especially the ones harboring progenitors.
Pou3f2 and Nrn1 as possible targets for a neurogenic fate were moderately up-regulated. POU3F2 collaborates with MASH1 to induce cell cycle exit and neurogenesis (44) . NRN1 is a factor for synapse formation (45) . In contrast, FOXG1, as a cooperator of BMI-1 and a competitor of FOXO3 for the DNA binding in the promoter of p21 in maintaining stem cells in a selfrenewal state, was down-regulated in forebrain from dtg animals (14, 46) . Hence, some proneurogenic factors are overexpressed, whereas a progenitor marker was underrepresented in our dtg mice.
Of the known target genes of FOXOs, we observed small, but statistically significant, changes of p27, Bim, and TRAIL at E11.5. However, it is unclear whether the amplitude of these known FOXO3 target genes could explain for the observed increase in apoptosis. In the further search for genes that may account for the increased apoptosis, we identified Pik3ip1, a gene that was also found to be regulated in loss-of-function experiments of FoxOs (12, 22) . PIK3IP1 augments apoptosis after a primary (proapoptotic) stimulus and an attenuation of Pi3k function by directly inhibiting it and, henceforth, further downstream pro survival pathways (36, 37) . Given the degree of up-regulation of Pik3ip1 at E12.5 and the observed amount in apoptosis, Pik3ip1 may well account for these effects. We have shown that Pik3ip1 is indeed a direct target gene of FOXO3 and that it is capable of promoting apoptosis in differentiating embryonic neural progenitors.
We have shown here increased apoptosis in the ventricular zone of CaMKII␣ FoxO3-CA mice during embryonic and postnatal development, and an expression signature pointing toward the fact that progenitors are already being lost early in mice expressing a FoxO3-CA allele. PIK3IP1 may augment these proapoptotic stimuli by blunting the antiapoptotic PI3K pathway, leading to enhanced apoptosis in the cortical progenitor populations. Our data demonstrate that mature neurons are far less susceptible to FOXO3-CA than progenitor populations, as we demonstrated a reduced overall cortex thickness, a proportional reduction in all cortical layers, and enhanced apoptosis only in the DG of young mice with no significant increase in apoptosis in the striatum. Constitutive activation of FOXO3 in CaMKII␣-positive neural progenitors in adult mice leads also to an impaired development of structures depending on adult neurogenesis. Therefore, we conclude that FOXO3 exerts distinct functions in neural progenitors and differentiated neurons.
In this report, we describe Pik3ip1 as a FOXO3 target gene that may enhance preexisting proapoptotic stimuli. Because this protein has been described by others to inhibit PI3K signaling, the question about this positive feedback loop arises.
PIK3IP1 might reinforce signaling leading to FoxO3 activation, such as cellular stress or energy depletion. While FOXO3 is active when PI3K-AKT signaling is low, this feedback loop could enhance proapoptotic FOXO3 activity by further blunting the PI3K-AKT pathway. 
